Home › Studies › PRJNA1430192
PRJNA1430192 SRP716493

Gut microbiome in older adults given probiotic KM2-HPB01

Shotgun metagenomic sequencing of human fecal samples from adults aged 50 years and older participating in a randomized placebo-controlled trial of KM2-HPB01

198 fecal samples from adults aged 50 and older in a randomized, placebo-controlled trial testing the probiotic intervention KM2-HPB01, analyzed by shotgun metagenomic sequencing to assess gut microbial composition and function. machine-written summary

198 samples · 198 runs · KR · Adult · 2026 · 4.40 Gbp / sample

Sources
✓Sequence archive 990✓Abstract / description 396–Full text–Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive990 sample values (collection date, country, intervention, subject id, timepoint)
✓ Abstract / description396 sample values (health condition, health condition detail)
– Full textno open-access full text linked
– Supplementary tablesno supplementary tables available (or none open access)
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Interventions

intervention · arms resolved

ROther administered intervention (see intervention_detail): 32 people · 96 samplesother 32 people · 96 samplesPlacebo / sham arm (sample level only): 34 people · 102 samplesplacebo 34 people · 102 samples
randomised to parallel arms

Probiotic (live microorganisms; single strain or mixture) design randomized_controlled_trial · population healthy_control · KM2-HPB01 probiotic vs placebo in adults 50+

“randomized, placebo-controlled clinical trial investigating the effects of KM2-HPB01” — bioproject.description (study level; per-sample arms are in the intervention column below)

Samples at a glance
1 country
Age
adult198
Condition
healthy_control198
Country
KR198
Body site
primary198
Collected 2023–2024
2023: 92 samples2024: 106 samples20232024
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 198 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)all projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 4.40 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal

66 of 66 people sampled more than once (198 samples; median 3, up to 3 per person) · follow-up median 3 mo (max 3 mo) · median interval between samples 42 d (time from collection dates). Schedule stated by the source: “Each subject sampled at week 0 (baseline), week 6, and week 12 of the trial” (time origin: intervention start (trial enrollment/baseline, week 0)); stated follow-up 3 mo.

P001P001: day 0P001: day 39P001: day 82P002P002: day 0P002: day 39P002: day 82P003P003: day 0P003: day 43P003: day 83P004P004: day 0P004: day 39P004: day 87P005P005: day 0P005: day 43P005: day 84P006P006: day 0P006: day 40P006: day 89P007P007: day 0P007: day 40P007: day 82P008P008: day 0P008: day 43P008: day 85P009P009: day 0P009: day 39P009: day 84P010P010: day 0P010: day 39P010: day 81P011P011: day 0P011: day 39P011: day 81P012P012: day 0P012: day 45P012: day 83P013P013: day 0P013: day 41P013: day 81P014P014: day 0P014: day 41P014: day 80P015P015: day 0P015: day 41P015: day 83P016P016: day 0P016: day 39P016: day 82P017P017: day 0P017: day 39P017: day 82P018P018: day 0P018: day 41P018: day 84P019P019: day 0P019: day 41P019: day 81P020P020: day 0P020: day 40P020: day 85P021P021: day 0P021: day 41P021: day 85P022P022: day 0P022: day 40P022: day 82P023P023: day 0P023: day 41P023: day 86P024P024: day 0P024: day 35P024: day 83P025P025: day 0P025: day 42P025: day 82P026P026: day 0P026: day 44P026: day 86P027P027: day 0P027: day 41P027: day 83P028P028: day 0P028: day 42P028: day 83P029P029: day 0P029: day 42P029: day 84P030P030: day 0P030: day 41P030: day 82P031P031: day 0P031: day 49P031: day 85P032P032: day 0P032: day 49P032: day 85P033P033: day 0P033: day 43P033: day 88P034P034: day 0P034: day 41P034: day 98T001T001: day 0T001: day 43T001: day 82T002T002: day 0T002: day 39T002: day 830 d24 d49 d2 mo3 mo

Each row is one person (36 shown of 66); dots are samples at days since that person's first sample.

How longitudinal and relatedness information is derived

Community composition

No Sandpiper profile for this project's samples yet.

Field coverage
fieldsamplescoverageR1R2R3R4
age_category198 100%
country198 100%198
health_condition198 100%198
subject_id198 100%198
collection_date198 100%198
health_condition_detail198 100%198
intervention198 100%198
timepoint_label198 100%198
Details
Archive description

This BioProject contains shotgun metagenomic sequencing data generated from human fecal samples collected from adults aged 50 years and older enrolled in a randomized, placebo-controlled clinical trial investigating the effects of KM2-HPB01 administration on gut microbiome composition. Paired-end Illumina sequencing was performed to characterize microbial community structure and functional potential.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “sequencing of human fecal samples from adults”
  • body site study.description · “generated from human fecal samples collected from”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • life stage study.title · “fecal samples from adults aged 50 years”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMN61422580collection_date2023-10-12R10.90biosample.attribute:collection_date2023-10-12
SAMN61422580countryKRR10.90sample.attr.geo_loc_nameSouth Korea
SAMN61422580health_conditionhealthy_controlR40.50study.titlerandomized placebo-controlled trial of KM2-HPB01
SAMN61422580health_condition_detailintervention trial with KM2-HPB01 vs placeboR40.50study.titlerandomized placebo-controlled trial of KM2-HPB01
SAMN61422580interventionother_interventionR10.70sample.name_rule:sample_aliasKM2_T001_W0
SAMN61422580subject_idT001R10.70sample.name_rule:sample_aliasKM2_T001_W0
SAMN61422580timepoint_labelweek 0R10.70sample.name_rule:sample_aliasKM2_T001_W0
Sequencing

198 runs over 198 samples · mean 4.49 Gbp per run (median 4.40 Gbp, total 888.28 Gbp; 198 runs with a base count) · layout PAIRED 198 · platform ILLUMINA 198 · models NextSeq 2000 (198) · 0% of runs with a Sandpiper profile · first public 2026-09-01

Authors (0)

No author record.

Downloads

PRJNA1430192.csv.gz (6.3 KB) · parquet (77.8 KB) — all 198 samples, every field with route and confidence · PRJNA1430192_determinations.csv.gz (10.7 KB) — 1,386 evidence rows

Samples (198 · every field this project has values for · hover a cell for its source)
Loading the sample table…